Clinical Trials in Russia - First Issue of SynRG Orange Paper

Moscow, Russia, May 16, 2007 --(PR.com)-- On April 25, 2007, the first issue of the Orange Paper – the first analytical review on market of clinical trials in Russia – was officially presented. The strategic goals of Synergy Research Group, a Russia-based emerging CRO, are formation of a civilized market of clinical trials in Russia, raising the country’s research attractiveness for foreign sponsors, and exoneration of clinical trials in Russian public opinion.

The Orange Paper – a series of regular reviews of the Russian market of clinical trials – will be the first step in this direction. The reports will be published in Russia both in the electronic and hard-copy form. While the English-language version will be distributed abroad by subscription and on popular websites dedicated to clinical trials, the hard-copy edition is to be distributed at international exhibitions and conferences on clinical trials.

The first issue presents the general overview of the Russian market of clinical trials as for the beginning of 2007. The quarterly publications to follow will elaborate in a more detailed way the subjects tackled in the review: general possibility of conducting clinical trials in Russia, review of the current legislative base, analysis of clinical trials being held in Russia today (by their sponsors, stages and therapeutic fields), rating of the most active foreign and Russian medication developers, review of services and rating of contract research organizations operating in Russia, review of research centers, laboratories, facilities for storage of samples, and other service suppliers for holding clinical trials in Russia.

According to Nikolay Odintsov, the Director General of Synergy Research Group, “the document opens a series of publications meant to provide all the concerned people with objective and unbiased, and (which is the most important) fresh and up-to-date information on the market of clinical trials in Russia.”

Synergy Research Group (SynRG™) is a Russian contract research organization, which has been successfully operating all over Russia and the CIS member-states since 2002. SynRG™ offers a broad range of services for conducting clinical trials for Russian and foreign pharmaceutical and biotechnological companies – from registration of the studies in regulatory authorities to pharmaco-economic surveys. The company has its own storehouse of clinical samples in Moscow, with the total area of 180 square meters. Today, Synergy Research Group is represented in Moscow, Saint-Petersburg, Novosibirsk, Yekaterinburg and Almaty. The company’s headquarters are in Moscow.

###